Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sorbent Therapeutics
With
Pharmaterra
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Heart failure with New York Heart Association (NYHA) Classification III or IV
Hospitalization for heart failure decompensation associated with fluid overload within the last six months
Chronic kidney disease
Must be able to understand study procedures and willing and able to provide written informed consent
You may not be if
No hospitalization within 4 weeks of Baseline Visit
In the investigator's judgment, any cardiovascular, renal, hepatic, endocrine, gastrointestinal, neurological or other disease or condition that makes the patients study participation unsafe
History or presence of gastrointestinal conditions such as severe constipation or gastrointestinal tract strictures
Current dialysis patient, or anticipated need for dialysis during study participation
